Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present at two upcoming scientific conferences, including the 12th International Congress on Targeted Anticancer Therapies , where a poster with data from a Phase 1 trial of VS-6063 , a potent ... (more)
http://ift.tt/MuRW7s
http://ift.tt/MuRW7s
No comments:
Post a Comment